期刊文献+

血管免疫母细胞T细胞淋巴瘤^(18)F-FDGPET/CT的影像表现及其在临床分期中的价值 被引量:1

^(18)F-FDG PET/CT imaging findings of angioimmunoblastic T-cell lymphoma and its value in clinical staging
下载PDF
导出
摘要 目的分析血管免疫母细胞T细胞淋巴瘤(angioimmunoblastic T-cell lymphoma,AITL)18 F-FDG PET/CT的影像学表现及分布规律,探讨其在临床分期中的价值。方法回顾性分析22例AITL患者的18 F-FDG PET/CT显像结果,评价其在临床分期中的价值。结果 (1)AITL结内侵犯的18 F-FDG PET/CT影像学表现:①全身弥漫性分布:左右对称性分布9例(40.9%),左右不对称性分布2例(9.1%);②多部位散在分布:与淋巴链走行有关4例(18.2%),与淋巴链走行无关5例(22.7%);③单部位局限性分布2例(9.1%);(2)AITL结外侵犯的18 F-FDG PET/CT影像学表现:鼻咽部侵犯最常见有10例,其余依次为口咽8例,脾脏8例,骨骼及骨髓5例,胃肠道4例,肺、胸膜及皮肤各2例,乳腺及颅内侵犯各1例;(3)在AITL分期中的价值:PET/CT显像改变了4例(18.2%,4/22)患者的分期,均为分期上调。结论血管免疫母细胞T细胞淋巴瘤呈18F-FDG高摄取;其在病灶检测及分期方面,18F-FDG PET/CT显像有优势。 Objective To analyse the imaging findings and distribution of ^18F-FDG PET/CT in angioimmunoblastic T cell lymphoma (AITL), and to evaluate the value of ^18F-FDG PET/CT in the clinical staging. Methods We retrospective ly analysed ^18 F-FDG PET/CT imaging findings of 22 patients with AITL, and evaluated its value in the clinical staging. Results ()1The imaging findings and distribution of ^18F-FDG PET/CT in AITL with nodal involvement. ① Whole-body multiple lesions with diffuse distribution: symmetrical distribution was observed in 9 of 22 patients (40.9%), and asym metrical distribution was observed in 2 of 22 patients (9.1 %) ; ② Multi-lesions in multi-locations with scattering distribu tion: lesions traveling along the lymphatic chain were observed in 4 of 22 patients (18.2%), and lesions without traveling along the lymphatic chain were observed in 5 of 22 patients (22.70/00) ; ③ Limited distribution was observed in 2 of 22 pa tients (9.1 %). (2) The imaging findings of JSF-FDG PET/CT in AITL with extranodal involvement. The more frequent sites of the lymphoma lesions were nasopharynx (10/22), oropharynx (8/22), spleen (8/22), bone and bone marrow (5/ 22), gastrointestinal (4/22), lung (2/22), pleura (2/22), skin (2/22), breast (1/22), brain (1/22). (3) The value of 18 F-FDG PET/CT imaging in the clinical staging of AITL. The stage of disease was changed in four patients on the basis of 18F-FDG PET/CT. All patients were upstaged. Conclusion The lesions of AITL are ^18F-FDG avid, and PET/CT seems to be useful in detecting and staging of this disease.
出处 《医学影像学杂志》 2013年第12期1887-1890,共4页 Journal of Medical Imaging
关键词 血管免疫母细胞T细胞淋巴瘤 正电子发射型计算机断层扫描 ^18氟-氟代脱氧葡萄糖 临床分期 Angioimmunoblastic T-cell lymphoma Positron emission tomography Fluorine-18 fluoro-deoxy-glucose Clinical staging
  • 相关文献

参考文献13

  • 1Dogan A, Jaffe ES, Ralfkiaer E, et al. Angioimmunoblastic T-cell lymphoma. World Health Organization classification of tumors of haematopoietic and lymphoid tissue [M]. Iarc Ly- on, 2008. 309-311.
  • 2Ailen-Auerbach M, de Vos S, Czernin J. The impact of fluo ro-deoxy-glucose positron emission tomography in primary staging and patient management in lymphoma patients [J]. Radiol Clin North Am, 2008, 46: 199-211.
  • 3Terasawa T, Nihashi T, Hotta T, et al. 18F-FDG PET for posttherapy assessment of Hodgkin' s disease and aggressive non-Hodgkin's lymphoma: a systematic review [J]. J Nucl Med, 2008, 49: 13-21.
  • 4王全师,吴湖炳,王明芳,郭晓君.^(18)F-FDG显像对淋巴瘤分期及疗效评价的价值[J].中华核医学杂志,2004,24(1):8-10. 被引量:30
  • 5Cho YU, Chi HS, Park CJ, et al. Distinct features of angio- immunoblastic T-cell lymphoma with bone marrow involve- ment [J]. Am J Clin Pathol, 2009, 131: 640-646.
  • 6方成,徐卫,李建勇.血管免疫母细胞T细胞淋巴瘤的研究进展[J].中华内科杂志,2010,49(4):348-350. 被引量:5
  • 7Weiler-Sagie M, Busheler O, Epelbaum R, et al. 18F-FDG a vidity in lymphoma readdressed: a study of 766 patients [J]. J Nucl Med, 2010, 51: 25-30.
  • 8Storto G, Di Giogrio E, De Renzo A, et al. Assessnent of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma [J]. Br J Haematol, 2010, 151: 195-197.
  • 9高海燕,宋文忠,谢红军,刘浩,刘兆辉.^(18)F-FDG PET/CT SUVmax与淋巴瘤临床分期、病理分级关系的探讨[J].医学影像学杂志,2010,20(5):679-681. 被引量:11
  • 10Lopci E, Zanoni L, Chiti A, et al. FDG PET/CT predictive role in follicular lymphoma [J]. Eur J Nucl Med Mol Ima ging, 2012, 39:864-871.

二级参考文献44

  • 1谢毅 见:叶任高 主编.淋巴瘤[A].见:叶任高,主编.内科学:第5版[C].北京:人民卫生出版社,2002.640-648.
  • 2Delcambre C, Reman O, Henry-Amar M, et al. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy[J]. Eur J Nucl Med, 2000,27: 176- 184.
  • 3Jhamwar YS, Straus DJ. The role of PET in lymphoma[J]. J Nucl Med,2006,47 : 1326 - 1334.
  • 4Schder H, Meta J, Yap C, et al. Effect of whole-body ^18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma[J]. J Nucl Med, 2001,42:1139 - 1143.
  • 5Kostakoglu L, Goldsmith SJ. Positron emission tomography in lymphoma: comparison with computed tomography and gallium-67 single photon emission computed tomography[J]. Clin Lymphoma, 2000,1: 67 - 74.
  • 6Stumpe KD, Urbinelli M, Steinert HC, et al. Whole-bedy positron emission tomography using fluoredeoxyglucose for staging of lymphoma: Effectiveness and comparison with computed tomography[J]. Eur J Nucl Med, 1998,25:721 - 728.
  • 7Buchmann I, Reinhardt M, Eisner K, et al. 2-(fluorine-18)fluoro-2- deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma[ J]. A bicenter trial. Cancer, 2001,91 : 889 - 899.
  • 8Moog F, Bangerter M, Diederichs CG, et al. Extranodal malignant lymphoma: detection with FDG PET versus CT[J]. Radiology, 1998, 206:475-481.
  • 9Shah N, Hoskin P, McMillan A,et al. The impact of FDG positron emission tomography imaging on the management of lymphomas[J]. Br J Radiol, 2000, 73:482 - 487.
  • 10Moog F, Bangerter M, Diederichs CG, et al. Lymphoma: Role of whole-body 2-deoxy-2-^18F fluoro-D-glucose (FDG) PET in nodal staging[J]. Radiology, 1997,203:795-800.

共引文献44

同被引文献15

  • 1Otsuka H. The utility of FDG-PET in the diagnosis of thymic epi thelial tumors. J Med Invest, 2012,59(3/4) :225-234.
  • 2Liu Y. Characterization of thymic lesions with F-18 FDG PET-CT: An emphasis on epithelial tumors. Nucl Med Commun, 2011,32(7) : 554-562.
  • 3Kumar A, Regmi SK, Dutta R, et al. Characterization of thymic masses using (18)F-FDG PET-CT. Ann Nuel Med, 2009, 23 (6) :569-577.
  • 4Gawande RS, Khurana A, Messing S, et al. Differentiation of normal thymus from anterior mediastinal lymphoma and lympho- ma recurrence at pediatric PET/CT. Radiology, 2012, 262 (2) : 613-622.
  • 5Le Dortz L, De Guibert S, Bayat S, et al. Diagnostic and prog- nostic impact of zSF-FDG PET/CT in follicular |ymphoma. Eur J Nucl Med Mol Imaging, 2010, 37(12):2307-2314.
  • 6Richardson SE, Sudak J, Warbey V, et al. Routine bone mar- row biopsy is not necessary in the staging of patients with classi cal Hodgkin lymphoma in the t8 F-fluoro-2-deoxyglucose positron emission tomography era. Leuk Lymphoma, 2012, 53 (3) : 381- 385.
  • 7Moulin-Romsee G, Hindi6 E, Cuenca X, et al. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkins lymphoma may circumvent the use of bone marrow trephine biopsy at diag- nosis staging. Eur J Nucl Med Mo| Imaging, 2010,37(6):1095 1105.
  • 8Zhang Z, Liu J, Liu Y, et al. Generation, characterization and potential therapeutic applications of mature and functional hepa- tocytes from stem cells. J Cell Physiol, 2013,228(2):298-305.
  • 9Sakaguchi Y, Isowa N. Successful resection of mediastinal semi- noma evaluated the response to induction chemotherapy with flu- orodeoxyglucose-positron emission tomography. Ann Thorac Cardiovasc Surg, 2012,18(1) :45 47.
  • 10颜有霞,张金娥,陈小聪,金新安,蔡淑芳.前纵隔淋巴瘤的影像学分析[J].实用放射学杂志,2008,24(7):903-904. 被引量:16

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部